Carmella Doss
Physician Assistant · Johnston City, ILNPI 1487758892
Payments from drug & device makers
Across 92 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$433
- GSK$226
- Lilly USA, LLC$130
- AstraZeneca$117
- Novo Nordisk$76
- Biohaven Pharmaceutical Holding Company Ltd.$60
- plus $351 from 12 others
What the payments were for
- Food & beverage$1,393100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $433 |
| GSK | 15 | $226 |
| Lilly USA, LLC | 8 | $130 |
| AstraZeneca | 8 | $117 |
| Novo Nordisk | 4 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Alkermes, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Bayer | 2 | $43 |
| Sumitomo Pharma America, Inc. | 3 | $37 |
| Boehringer Ingelheim | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Exact Sciences | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Novartis | 1 | $19 |
| Dexcom, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$1,393 in reported general payments places this provider in the 75th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 38 | $38,705 |
| EliquisApixaban | 32 | $37,202 |
| OzempicSemaglutide | 38 | $36,689 |
| FarxigaDapagliflozin Propanediol | 43 | $33,715 |
| XareltoRivaroxaban | 16 | $12,017 |
| JanuviaSitagliptin Phosphate | 15 | $11,642 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $6,932 |
| TrintellixVortioxetine Hydrobromide | 12 | $5,454 |
| Levothyroxine Sodium | 231 | $2,932 |
| Atorvastatin Calcium | 306 | $2,853 |
| LantusInsulin Glargine,hum.Rec.Anlog | 23 | $1,657 |
| Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm | 14 | $1,564 |
| SynthroidLevothyroxine Sodium | 14 | $1,539 |
| Lisinopril | 202 | $1,505 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $32 | $38,70538 claims |
| Novo NordiskOzempic | $76 | $36,68938 claims |
| AstraZenecaFarxiga | $117 | $33,71543 claims |
| AbbVieSynthroid | $433 | $1,53914 claims |
| Lilly USA, LLCHumulin 70-30 | $130 | $74515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Johnston City
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Darrel CutlerHerrin$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.